Beata Korytowsky

Beata Korytowsky serves as the Executive Director of Medical Strategy and Operations at Mirati Therapeutics since August 2020, following a diverse career in the healthcare sector. Prior experience includes a role as Value Strategist at Pfizer, Headquarters/WW Medical Director for Lung Immuno-Oncology at Bristol-Myers Squibb, and various positions in global health economics and clinical trials at Pfizer and Novartis. Additionally, Korytowsky holds the position of President at 218-220 Owners Corp since 2007 and has a strong foundation in research from Memorial Sloan-Kettering Cancer Center. Academic achievements include a Master’s degree in Biotechnology from Columbia University and a Bachelor’s degree in Chemistry and Economics from New York University.